PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
30-Jun-2021 Pharmaceutical Membrane Filtration Market: Emerging Trends and Developments MarketsandMarkets Research Private Ltd.
30-Jun-2021 Pharmaceutical Packaging Equipment Market worth $10.4 billion by 2025 MarketsandMarkets Research Private Ltd.
30-Jun-2021 Revenue Cycle Management Market: Trends and Developments MarketsandMarkets Research Private Ltd.
30-Jun-2021 Sickle cell gene therapy granted new ‘innovation passport’ under MHRA scheme to reduce the time to market for innovative medicines bluebird bio
30-Jun-2021 AI in Medical Diagnostics Market worth $3,868 million by 2025 MarketsandMarkets Research Private Ltd.
30-Jun-2021 Cell Expansion Market:Growing focus on personalized medicine MarketsandMarkets Research Private Ltd.
30-Jun-2021 Hyperspectral Imaging Market Growth Strategies & Future Opportunities MarketsandMarkets Research Private Ltd.
30-Jun-2021 Continuous technological advancements in PCR technologies & dPCR and qPCR Market Development MarketsandMarkets Research Private Ltd.
30-Jun-2021 Flow Cytometry Market to Expand at a Healthy Growth Rate in the Coming Years MarketsandMarkets Research Private Ltd.
30-Jun-2021 Heart Pump Device Market worth $5.5 billion - Rising prevalence of Cardiovascular Diseases and China to Drive Growth MarketsandMarkets Research Private Ltd.
30-Jun-2021 Topical Drug Delivery Market - Emerging Trends to Boost the Global Industry Growth MarketsandMarkets Research Private Ltd.
30-Jun-2021 Clinical Trial Supplies Market - Increasing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry MarketsandMarkets Research Private Ltd.
30-Jun-2021 NGS Sample Preparation Market - Emerging Advancements in NGS Platforms MarketsandMarkets Research Private Ltd.
29-Jun-2021 AARDEX Group and AdhereTech Partnership Boosts Medication Adherence with Software, Data Analytics and Smart Pill Bottle AARDEX Group
29-Jun-2021 CluePoints’ Launch Post-COVID Trial Assurance Solution CluePoints
29-Jun-2021 Investigational 2.0 mg dose of Ozempic® (semaglutide) demonstrates superior reductions in blood sugar vs Ozempic® 1.0 mg in adults with type 2 diabetes in a phase 3 trial Novo Nordisk
29-Jun-2021 First Head & Neck Cancer Patient Enrolled in the UK in a Phase I Trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy Transgene
29-Jun-2021 Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial Sanofi
29-Jun-2021 Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes Boehringer Ingelheim
29-Jun-2021 Vaxzevria induced immunity for at least one year following a single dose and strong immune responses following either a late second dose or a third dose AstraZeneca